What’s new

• MD Aspi Nariman Katgara resigned; Cyrus Khambara was appointed as his replacement.
• Two independent directors also quit the board.
• Audited standalone profit dropped to ₹2.71 cr from ₹11.69 cr a year earlier.

Why it matters

A nano-cap with a ₹145 cr market cap replaced its Managing Director and two independent directors in the same filing. The simultaneous exit of key board members, coupled with an unresolved auditor dispute now in its seventh year, points to deeper governance issues than a routine results cycle.

What we’re watching

• The new MD's plan to resolve the long-standing ₹3.82 cr auditor qualification.
• Any regulatory response to the concentrated board turnover.
• How the company plans to stabilize its leadership after a complete overhaul.

The full read

Maha Rashtra Apex Corporation replaced its Managing Director and two independent directors in the same filing where it disclosed a 77% annual profit drop to ₹2.71 crore. The auditor's qualified opinion, flagging ₹3.82 crore in unpaid deposit interest, marks its seventh consecutive year. For a company with a ₹145 crore market cap, the leadership churn is the bigger story. New MD Cyrus Khambara inherits a board with fresh vacancies and a long-running accounting dispute his predecessor could not settle. The financials are weak, but the governance picture is worse.

Primary source: BSE · NSE